<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">12556</article-id><article-id pub-id-type="doi">10.7554/eLife.12556</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title><italic>Toxoplasma gondii</italic> peptide ligands open the gate of the HLA class I binding groove</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-44626"><name><surname>McMurtrey</surname><given-names>Curtis</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology</institution>, <institution>University of Oklahoma Health Sciences Center</institution>, <addr-line><named-content content-type="city">Oklahoma City</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45536"><name><surname>Trolle</surname><given-names>Thomas</given-names></name><aff><institution content-type="dept">Center for Biological Sequence Analysis</institution>, <institution>Technical University of Denmark</institution>, <addr-line><named-content content-type="city">Kongens Lyngby</named-content></addr-line>, <country>Denmark</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45537"><name><surname>Sansom</surname><given-names>Tiffany</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology</institution>, <institution>University at Buffalo School of Medicine</institution>, <addr-line><named-content content-type="city">Buffalo</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45538"><name><surname>Remesh</surname><given-names>Soumya G</given-names></name><aff><institution>La Jolla Institute for Allergy and Immunology</institution>, <addr-line><named-content content-type="city">La Jolla</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45539"><name><surname>Kaever</surname><given-names>Thomas</given-names></name><aff><institution>La Jolla Institute for Allergy and Immunology</institution>, <addr-line><named-content content-type="city">La Jolla</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45540"><name><surname>Bardet</surname><given-names>Wilfried</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology</institution>, <institution>University of Oklahoma Health Sciences Center</institution>, <addr-line><named-content content-type="city">Oklahoma City</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45541"><name><surname>Jackson</surname><given-names>Kenneth</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology</institution>, <institution>University of Oklahoma Health Sciences Center</institution>, <addr-line><named-content content-type="city">Oklahoma City</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45542"><name><surname>Nielsen</surname><given-names>Morten</given-names></name><aff><institution content-type="dept">Center for Biological Sequence Analysis</institution>, <institution>Technical University of Denmark</institution>, <addr-line><named-content content-type="city">Kongens Lyngby</named-content></addr-line>, <country>Denmark</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45543"><name><surname>McLeod</surname><given-names>Rima</given-names></name><aff><institution>University of Chicago</institution>, <addr-line><named-content content-type="city">Chicago</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45544"><name><surname>Zajonc</surname><given-names>Dirk M</given-names></name><aff><institution>La Jolla Institute for Allergy and Immunology</institution>, <addr-line><named-content content-type="city">La Jolla</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-41666"><name><surname>Blader</surname><given-names>Ira J</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology</institution>, <institution>University at Buffalo School of Medicine</institution>, <addr-line><named-content content-type="city">Buffalo</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45545"><name><surname>Peters</surname><given-names>Bjoern</given-names></name><aff><institution>La Jolla Institute for Allergy and Immunology</institution>, <addr-line><named-content content-type="city">La Jolla</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49868"><name><surname>Sette</surname><given-names>Alessandro</given-names></name><aff><institution>La Jolla Institute for Allergy and Immunology</institution>, <addr-line><named-content content-type="city">La Jolla</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-44842"><name><surname>Hildebrand</surname><given-names>William</given-names></name><aff><institution content-type="dept">Department of Microbiology and Immunology</institution>, <institution>University of Oklahoma Health Science Center</institution>, <addr-line><named-content content-type="city">Oklahoma City</named-content></addr-line>, <country>United States</country><email>william-hildebrand@ouhsc.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-43200"><name><surname>Gilmore</surname><given-names>Michael S</given-names></name><role>Reviewing editor</role><aff><institution>Harvard Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>29</day><month>01</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e12556</elocation-id><supplementary-material><ext-link xlink:href="elife-12556-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>26</day><month>10</month><year>2015</year></date><date date-type="accepted"><day>28</day><month>01</month><year>2016</year></date></history><permissions><copyright-statement>Â© 2016, McMurtrey et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>McMurtrey et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>HLA class I presentation of pathogen-derived peptide ligands is essential for CD8+ T-cell recognition of <italic>Toxoplasma gondii</italic> infected cells. Currently, little data exist pertaining to peptides that are presented after <italic>T. gondii</italic> infection. Herein we purify HLA-A*02:01 complexes from <italic>T. gondii</italic> infected cells and characterize the peptide ligands using LCMS. We identify 195 <italic>T. gondii</italic> encoded ligands originating from both secreted and cytoplasmic proteins. Surprisingly, <italic>T. gondii</italic> ligands are significantly longer than uninfected host ligands, and these longer pathogen-derived peptides maintain a canonical N-terminal binding core yet exhibit a C-terminal extension of 1-30 amino acids. Structural analysis demonstrates that binding of extended peptides opens the HLA class I F' pocket, allowing the C-terminal extension to protrude through one end of the binding groove. In summary, we demonstrate that unrealized structural flexibility makes MHC class I receptive to parasite-derived ligands that exhibit unique C-terminal peptide extensions.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Other</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>